Role of External Pallidal Segment in Primate Parkinsonism: Comparison of the Effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism and Lesions of the External Pallidal Segment

These experiments re-examined the notion that reduced activity in the external pallidal segment (GPe) results in the abnormalities of neuronal discharge in the subthalamic nucleus (STN) and the internal pallidal segment (GPi) and in the development of parkinsonian motor signs. Extracellular recording in two rhesus monkeys, which had been rendered parkinsonian by treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), revealed that the average neuronal discharge rate decreased in GPe but increased in STN and GPi. After MPTP, neurons in all three nuclei tended to discharge in oscillatory bursts. In addition, GABA release in STN (measured with microdialysis) was reduced, indicative of reduced activity along the GPe-STN pathway. Finally, the concentration of glutamic acid dehydrogenase (GAD; measured with autoimmunoradiography) was increased in GPe and GPi, likely reflecting increased striatal input and increased activity of local axon collaterals, respectively. Surprisingly, GAD protein in STN remained unchanged, indicating that the usual assumption that GAD levels are determined primarily by the overall activity of GABAergic elements may be too simplistic. The results from the MPTP-treated animals were compared with results obtained in a second group of three animals with ibotenic acid lesions of GPe. GPe lesions resulted in increased discharge in STN and GPi, comparable with the changes seen after MPTP but did not induce oscillatory bursting and had no behavioral effects. The results indicate that a mere reduction of GPe activity does not produce parkinsonism. Other changes, such as altered discharge patterns in STN and GPi, may play an important role in the generation of parkinsonism.

[1]  T. Wichmann,et al.  Pathophysiology of Parkinson's Disease: The MPTP Primate Model of the Human Disorder , 2003, Annals of the New York Academy of Sciences.

[2]  J. Schneider,et al.  Experimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site‐directed antisense gene therapy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[3]  M. Delong,et al.  Functional neuroanatomy of the basal ganglia in Parkinson's disease. , 2003, Advances in neurology.

[4]  Charles J. Wilson,et al.  Move to the rhythm: oscillations in the subthalamic nucleus–external globus pallidus network , 2002, Trends in Neurosciences.

[5]  Steven W. Johnson,et al.  Excitatory effects of dopamine on subthalamic nucleus neurons: in vitro study of rats pretreated with 6-hydroxydopamine and levodopa , 2002, Brain Research.

[6]  P. Salin,et al.  High-Frequency Stimulation of the Subthalamic Nucleus Selectively Reverses Dopamine Denervation-Induced Cellular Defects in the Output Structures of the Basal Ganglia in the Rat , 2002, The Journal of Neuroscience.

[7]  P. Salin,et al.  Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat , 2002, The European journal of neuroscience.

[8]  Thomas Wichmann,et al.  Effects of Transient Focal Inactivation of the Basal Ganglia in Parkinsonian Primates , 2002, The Journal of Neuroscience.

[9]  J. Bolam,et al.  Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus–globus pallidus network , 2001, Neuroscience.

[10]  M. Delong,et al.  Antiparkinsonian and Behavioral Effects of Inactivation of the Substantia Nigra Pars Reticulata in Hemiparkinsonian Primates , 2001, Experimental Neurology.

[11]  J. Schneider,et al.  Alterations in expression of messenger RNAs encoding two isoforms of glutamic acid decarboxylase in the globus pallidus and entopeduncular nucleus in animals symptomatic for and recovered from experimental Parkinsonism , 2001, Brain Research.

[12]  J. Obeso,et al.  Dorsal subthalamotomy for Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[13]  A. Benabid,et al.  Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat , 2000, The European journal of neuroscience.

[14]  E. Vaadia,et al.  Firing Patterns and Correlations of Spontaneous Discharge of Pallidal Neurons in the Normal and the Tremulous 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Vervet Model of Parkinsonism , 2000, The Journal of Neuroscience.

[15]  Y. Smith,et al.  Anatomy of the dopamine system in the basal ganglia , 2000, Trends in Neurosciences.

[16]  E. Hirsch,et al.  Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP‐treated monkeys, and in Parkinson's disease patients , 2000, The Journal of comparative neurology.

[17]  E. C. Hirsch,et al.  Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease , 2000, Neuroscience.

[18]  J. Bolam,et al.  Relationship of Activity in the Subthalamic Nucleus–Globus Pallidus Network to Cortical Electroencephalogram , 2000, The Journal of Neuroscience.

[19]  D. Plenz,et al.  A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus , 1999, Nature.

[20]  Hagai Bergman,et al.  Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates , 1999, Experimental Brain Research.

[21]  S. Gill,et al.  Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease , 1997, The Lancet.

[22]  N. Laprade,et al.  Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of parkinsonian monkeys , 1997, Synapse.

[23]  J. Walters,et al.  The Response of Subthalamic Nucleus Neurons to Dopamine Receptor Stimulation in a Rodent Model of Parkinson’s Disease , 1997, The Journal of Neuroscience.

[24]  J A Obeso,et al.  Consequences of Nigrostriatal Denervation on the Functioning of the Basal Ganglia in Human and Nonhuman Primates: An In Situ Hybridization Study of Cytochrome Oxidase Subunit I mRNA , 1997, The Journal of Neuroscience.

[25]  Y. Agid,et al.  Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum , 1996, Neurology.

[26]  Y. Smith,et al.  The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey , 1996, Neuroscience.

[27]  O. Hassani,et al.  Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus , 1996, Neuroscience.

[28]  Y. Agid,et al.  Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease. , 1996, Advances in neurology.

[29]  M. Chesselet,et al.  Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  A. Parent,et al.  Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  F. Wiesel,et al.  Characterization of dopamine receptor binding sites in the subthalamic nucleus. , 1994, Neuroreport.

[32]  S. Pedneault,et al.  Glutamate decarboxylase (GAD65) mRNA levels in the striatum and pallidum of MPTP-treated monkeys. , 1994, Brain research. Molecular brain research.

[33]  H. Bergman,et al.  The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. , 1994, Journal of neurophysiology.

[34]  J. B. Justice,et al.  Quantitative microdialysis under transient conditions. , 1993, Analytical chemistry.

[35]  M. Delong,et al.  Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. , 1992, Journal of neurophysiology.

[36]  M. Chesselet,et al.  Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat , 1992, Synapse.

[37]  C. Marescaux,et al.  Contralateral disappearance of parkinsonian signs after subthalamic hematoma , 1992, Neurology.

[38]  R. Robertson,et al.  Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: an intracerebral microdialysis study of γ-aminobutyric acid in the lateral segment of the globus pallidus , 1991, Brain Research.

[39]  L. Tremblay,et al.  Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism , 1991, Brain Research.

[40]  W T Thach,et al.  Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. , 1991, Journal of neurophysiology.

[41]  H. Bergman,et al.  Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.

[42]  M. Delong,et al.  Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.

[43]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[44]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.

[45]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[46]  B. Yamamoto,et al.  A rapid and simple HPLC microassay for biogenic amines in discrete brain regions , 1988, Pharmacology Biochemistry and Behavior.

[47]  A. Graybiel,et al.  [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: Delineation of striosomal compartments and pallidal and nigral subdivisions , 1988, Neuroscience.

[48]  M. Delong,et al.  Altered Tonic Activity of Neurons in the Globus Pallidus and Subthalamic Nucleus in the Primate MPTP Model of Parkinsonism , 1987 .

[49]  M. Carpenter,et al.  The Basal Ganglia II , 1987, Advances in Behavioral Biology.

[50]  D. Jacobowitz,et al.  Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1986, Life sciences.

[51]  F. F. Weight,et al.  Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis , 1985, Brain Research.

[52]  C. Legéndy,et al.  Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons. , 1985, Journal of neurophysiology.

[53]  M. Filion.  Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey , 1979, Brain Research.

[54]  R. Katzman.,et al.  Catecholaminergic innervation of the subthalamic nucleus: evidence for a rostral continuation of the A9 (substantia nigra) dopaminergic cell group , 1979, Brain Research.

[55]  W. R. Adey,et al.  A stereotaxic brain atlas for Macaca nemestrina , 1969 .